What is BNXTF stock price today?

BNXTF (BioNxt Solutions Inc.) stock is trading at $0.36 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is BNXTF stock going up or down today?

BNXTF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy BNXTF stock now?

The decision to buy BNXTF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is BNXTF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for BNXTF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is BNXTF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if BNXTF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is BNXTF's P/E ratio?

P/E ratio data for BNXTF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is BNXTF's market cap?

BNXTF (BioNxt Solutions Inc.) has a market capitalization of $0.04 billion, making it a small-cap stock.

What is BNXTF's price to book ratio?

BNXTF trades at a price-to-book (P/B) ratio of 21.77, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does BNXTF pay dividends?

BNXTF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is BNXTF's dividend yield?

BNXTF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is BNXTF stock a good long-term investment?

BNXTF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is BNXTF's revenue growth rate?

BNXTF has shown revenue growth of -0.3% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for BNXTF are available on our dashboard with complete income statement analysis.

What are the risks of investing in BNXTF?

Key risks for BNXTF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does BNXTF compare to its competitors?

Compare BNXTF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize BNXTF's performance and positioning.

What is BNXTF's stock price target for 2026?

Our AI model provides price targets for BNXTF based on fundamental analysis: Bull case $0.47 (+30%), Base case $0.42 (+15%), Bear case $0.33 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about BNXTF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for BNXTF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is BNXTF's next earnings report?

BNXTF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

BNXTF - BioNxt Solutions Inc.

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.36

+$0.00 (+0.00%)

About BioNxt Solutions Inc.

BioNxt Solutions Inc. engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland. The company provides BNT23001for the treatment of multiple sclerosis; BNT23002 for the treatment of myasthenia gravis; BNT24002, a sublingual thin film for the treatment of lupus nephritis; BNT24003 for the treatment of rheumatoid arthritis; BNT24004 for longevity and anti-aging; and BNT24004 for the treatment of semaglutide. It also offers diagnostic screening tests; new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; infectious disease and oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

BNXTF Key Statistics

Market Cap

$44.61M

P/B Ratio

21.77

EPS

$-0.04

Revenue Growth

-0.3%

How BNXTF Compares to Peers

BNXTF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
BNXTF(This stock)	$44.61M	N/A	-0%	0.0%	-
LLYEli Lilly	$933.47B	51.0	1%	0.3%	vs LLY
JNJJohnson &	$525.73B	21.1	0%	0.3%	vs JNJ
PFEPfizer Inc	$145.84B	14.9	-0%	0.2%	vs PFE
MRKMerck &	$273.38B	14.5	0%	0.3%	vs MRK
ABBVAbbvie Inc	$378.84B	161.2	0%	0.0%	vs ABBV

BioNxt Solutions Inc. Company Information

Headquarters: 1928 Linden Road, Vancouver, BC, Canada, V6M 1E7, undefined
Website: www.bionxt.com
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

About BioNxt Solutions Inc.

BNXTF Key Statistics

How BNXTF Compares to Peers

BioNxt Solutions Inc. Company Information

Upcoming Events for BNXTF